- Home
- APPF vs EXEL Comparison
APPF vs EXEL Comparison
Compare APPF & EXEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APPF
- EXEL
- Stock Information
- Founded
- APPF 2006
- EXEL 1994
- Country
- APPF United States
- EXEL United States
- Employees
- APPF N/A
- EXEL N/A
- Industry
- APPF Computer Software: Prepackaged Software
- EXEL Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- APPF Technology
- EXEL Health Care
- Exchange
- APPF Nasdaq
- EXEL Nasdaq
- Market Cap
- APPF 10.0B
- EXEL 10.4B
- IPO Year
- APPF 2015
- EXEL 2000
- Fundamental
- Price
- APPF $227.74
- EXEL $40.27
- Analyst Decision
- APPF Buy
- EXEL Buy
- Analyst Count
- APPF 6
- EXEL 22
- Target Price
- APPF $309.83
- EXEL $44.00
- AVG Volume (30 Days)
- APPF 259.1K
- EXEL 2.5M
- Earning Date
- APPF 10-30-2025
- EXEL 10-28-2025
- Dividend Yield
- APPF N/A
- EXEL N/A
- EPS Growth
- APPF 64.56
- EXEL 81.76
- EPS
- APPF 5.55
- EXEL 2.08
- Revenue
- APPF $862,674,000.00
- EXEL $2,230,005,000.00
- Revenue This Year
- APPF $21.11
- EXEL $9.10
- Revenue Next Year
- APPF $17.59
- EXEL $12.47
- P/E Ratio
- APPF $41.02
- EXEL $19.04
- Revenue Growth
- APPF 19.47
- EXEL 10.73
- 52 Week Low
- APPF $189.01
- EXEL $26.06
- 52 Week High
- APPF $326.04
- EXEL $49.62
- Technical
- Relative Strength Index (RSI)
- APPF 24.77
- EXEL 56.12
- Support Level
- APPF $222.91
- EXEL $37.52
- Resistance Level
- APPF $232.53
- EXEL $41.44
- Average True Range (ATR)
- APPF 7.55
- EXEL 1.08
- MACD
- APPF -3.76
- EXEL -0.08
- Stochastic Oscillator
- APPF 8.02
- EXEL 65.01
About APPF AppFolio Inc.
AppFolio Inc provides cloud-based software solutions for the real estate industry. Its property management software offers property managers an end-to-end solution to their business needs. The group's products include cloud-based property management software (Appfolio Property Manager). Its solutions are AppFolio Property Manager Core, AppFolio Property Manager Plus, and AppFolio Property Manager Max. It also offers value-added services, such as screening, risk mitigation, and electronic payment services. Its markets are Single-Family, Multifamily, Student Housing, Affordable Housing, Community Associations, Commercial, and Investment Management. The business activity of the firm predominantly functions in the United States and it generates revenue in the form of subscription fees.
About EXEL Exelixis Inc.
Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.